Thymic Stromal Lymphopoietin anticorps (Biotin)

N° du produit ABIN7608398

L’anticorps Human Chimeric anti-Thymic Stromal Lymphopoietin a été validé pour FACS. Il convient pour détecter Thymic Stromal Lymphopoietin dans des échantillons de Humain.

Aperçu rapide pour Thymic Stromal Lymphopoietin anticorps (Biotin) (ABIN7608398)

Antigène: Thymic Stromal Lymphopoietin (TSLP)

Reactivité: Humain

Hôte: Human, Lapin

Clonalité: Chimeric

Conjugué: Cet anticorp Thymic Stromal Lymphopoietin est conjugé à/à la Biotin

Application: Flow Cytometry (FACS)

Clone: DMC426

Détail du produit anti-Thymic Stromal Lymphopoietin anticorps (Biotin)

Fonction: Biotinylated Anti-TSLP antibody(DMC426), IgG1 Chimeric mAb

Purification: Purified from cell culture supernatant by affinity chromatography

Isotype: IgG1

Information d'application

Indications d'application: Flow Cyt 1:100

Restrictions: For Research Use only

Stockage

Format: Lyophilized

Buffer: Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.

Stock: -20 °C,-80 °C

Stockage commentaire: Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.

Date de péremption: 12 months

Détails sur Thymic Stromal Lymphopoietin

Antigène: Thymic Stromal Lymphopoietin (TSLP)

Autre désignation: TSLP

Sujet: This gene encodes a hemopoietic cytokine proposed to signal through a heterodimeric receptor complex composed of the thymic stromal lymphopoietin receptor and the IL-7R alpha chain. It mainly impacts myeloid cells and induces the release of T cell-attracting chemokines from monocytes and enhances the maturation of CD11c( ) dendritic cells. The protein promotes T helper type 2 (TH2) cell responses that are associated with immunity in various inflammatory diseases, including asthma, allergic inflammation and chronic obstructive pulmonary disease. The protein is therefore considered a potential therapeutic target for the treatment of such diseases. In addition, the shorter (predominant) isoform is an antimicrobial protein, displaying antibacterial and antifungal activity against B. cereus, E. coli, E. faecalis, S. mitis, S. epidermidis, and C. albicans. Alternative splicing of this gene results in multiple transcript variants.

UniProt: Q969D9